Login / Signup

IPEM topical report: guidance for the clinical implementation of online treatment monitoring solutions for IMRT/VMAT.

Simon W StevensStephen MoloneyAndrew BlackmoreClare HartPhilip RixhamAnna BangiriAlistair PoolerPaul James Doolan
Published in: Physics in medicine and biology (2023)
This report provides guidance for the implementation of online treatment monitoring (OTM) solutions in radiotherapy (RT), with a focus on modulated treatments. Support is provided covering the implementation process, from identification of an OTM solution to local implementation strategy. Guidance has been developed by a RT special interest group (RTSIG) working party (WP) on behalf of the Institute of Physics and Engineering in Medicine (IPEM). Recommendations within the report are derived from the experience of the WP members (in consultation with manufacturers, vendors and user groups), existing guidance or legislation and a UK survey conducted in 2020 (Stevens et al., 2021).

OTM is an inclusive term representing any system capable of providing a direct or inferred measurement of the delivered dose to a RT patient. Information on each type of OTM is provided but, commensurate with UK demand, guidance is largely influenced by in vivo dosimetry (IVD) methods utilising the electronic portal imager device (EPID).

Sections are included on the choice of OTM solutions, acceptance and commissioning methods with recommendations on routine quality control, analytical methods and tolerance setting, clinical introduction and staffing/resource requirements. The guidance aims to give a practical solution to sensitivity and specificity testing. Functionality is provided for the user to introduce known errors into treatment plans for local testing. Receiver operating characteristic (ROC) analysis is discussed as a tool to performance assess OTM systems. 

OTM solutions can help verify the correct delivery of radiotherapy treatment. Furthermore, modern systems are increasingly capable of providing clinical decision-making information which can impact the course of a patient's treatment. However, technical limitations persist. It is not within the scope of this guidance to critique each available solution, but the user is encouraged to carefully consider workflow and engage with manufacturers in resolving compatibility issues. &#xD.
Keyphrases
  • primary care
  • radiation therapy
  • early stage
  • decision making
  • squamous cell carcinoma
  • preterm infants
  • palliative care
  • case report
  • combination therapy
  • radiation induced
  • locally advanced